US President Donald Trump's administration has secured almost all the world's upcoming supply of the drug remdesivir.
The drug, produced by the firm Gilead Sciences, is the first approved by authorities in the US to be used to treat Covid-19.
It has been shown to help people recover faster from the disease.
A statement from the Department of Health and Human services says Trump struck an "amazing" deal with Gilead for 500,000 doses which amounts to 100% of Gilead's production in July, 90% of it in August and 90% in September.
A treatment course of remdesivir is, on average, 6.25 vials.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Anlo Dukor celebrates grand durbar of Anlo Hogbetsotso Za
14 mins -
Election 2024: Akufo-Addo pledges to respect Ghanaian will
29 mins -
EPL: Antoine Semenyo stars as Bournemouth defeat Manchester City
1 hour -
Watch CCTV footage of dramatic Adabraka daylight robbery
2 hours -
EPL: Liverpool come fron behind to beat Brighton
2 hours -
EPL: Jordan Ayew late goal salvages draw for Leicester against Ipswich
2 hours -
ESCO VOLTA holds meeting to strengthen cross-border cooperation in security, development
2 hours -
Kufuor Scholar champions Agricultural Innovation through Fidelity GreenTech Challenge
2 hours -
EPL: Isak scores at home again as Newcastle beat Arsenal
2 hours -
I’m proud that despite all the challenges, we have maintained Free SHS – Akufo Addo
5 hours -
Alan’s running mate, KOD says GRASP will revolutionize care for the Elderly in rural areas
6 hours -
Election 2024: Alan paints Accra yellow as the crowd marches through the capital with him
6 hours -
Vacant seats: Speaker has not done what would have led to greater peace – Kofi Bentil
6 hours -
Police on manhunt for Adabraka daylight robbers
6 hours -
Lordina Mahama presents medical supplies and equipment to Tishigu Health Center
6 hours